ACCESS TO ADVANCED HEALTH INSTITUTE: Form 990, tax year 2017
View the entire original 990 at ProPublica ↗
- Organization
- ACCESS TO ADVANCED HEALTH INSTITUTE (EIN 91-1608978)
- Tax period
- 2017-01-01 to 2017-12-31
- Filed
- 2018-11-15
- IRS object ID
- 201833199349311223
- Schema version
- 2017v2.3
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule B
- Schedule D
- Schedule F
- Schedule I
- Schedule J
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2018-11-15T14:16:08-06:00 | ReturnTs |
| Tax Period End | 2017-12-31 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Firm EIN | 911194016 | PreparerFirmEIN |
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CLARK NUBER PS | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 10900 NE 4TH STREET SUITE 1400 | AddressLine1Txt |
| City | BELLEVUE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2017-01-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 911608978 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | INFECTIOUS DISEASE RESEARCH INSTITUTE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Control | INFE | BusinessNameControlTxt |
| Phone | 2063810883 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1616 EASTLAKE AVE E NO 400 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98102 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | RICHARD LAUTCH | PersonNm |
| Person Title | CHIEF OPERATING OFFICER | PersonTitleTxt |
| Phone | 2063810883 | PhoneNum |
| Signature | 2018-11-14 | SignatureDt |
| Discuss With Paid Preparer | Yes (1) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | JANE M SEARING | PreparerPersonNm |
| PTIN | P00000565 | PTIN |
| Phone | 4254544919 | PhoneNum |
| Preparation | 2018-11-14 | PreparationDt |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 65.158.230.194 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| IP | 2018-11-14 | IPDt |
| IP Tm | 22:09:42 | IPTm |
| IP Timezone | PS | IPTimezoneCd |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | 2DE068ACBFA10A31F139242116409E8904B6E6F4 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | 0D4F8B5D50665025C0D74E3A044B1CC8CBA0177E | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2017 | TaxYr |
| Build TS | 2019-02-21 02:37:17Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | STEVEN R REED PHD | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1616 EASTLAKE AVE E NO 400 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98102 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $24,824,944 | GrossReceiptsAmt |
| Group Return For Affiliates | 0 | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | WWW.IDRI.ORG | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1993 | FormationYr |
| Legal Domicile State | WA | LegalDomicileStateCd |
| Activity Or Mission | DEVELOP VACCINES, ADJUVANTS, DIAGNOSTICS & DRUGS TO PREVENT, DETECT & TREAT INFECTIOUS DISEASES OF GLOBAL IMPORTANCE. | ActivityOrMissionDesc |
| Voting Members Governing Body | 11 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 8 | VotingMembersIndependentCnt |
| Total Employee | 160 | TotalEmployeeCnt |
| Total Volunteers | 8 | TotalVolunteersCnt |
| Total Gross UBI | $0 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $0 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $10,066,730 | PYContributionsGrantsAmt |
| CY Contributions Grants | $11,656,120 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $9,598,506 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $11,159,561 | CYProgramServiceRevenueAmt |
| PY Investment Income | $64,522 | PYInvestmentIncomeAmt |
| CY Investment Income | -$212,832 | CYInvestmentIncomeAmt |
| PY Other Revenue | $1,008,787 | PYOtherRevenueAmt |
| CY Other Revenue | $986,611 | CYOtherRevenueAmt |
| PY Total Revenue | $20,738,545 | PYTotalRevenueAmt |
| CY Total Revenue | $23,589,460 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $346,425 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $265,295 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $11,827,460 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $13,137,034 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $43,414 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $12,892,271 | PYOtherExpensesAmt |
| CY Other Expenses | $14,233,302 | CYOtherExpensesAmt |
| PY Total Expenses | $25,066,156 | PYTotalExpensesAmt |
| CY Total Expenses | $27,635,631 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | -$4,327,611 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | -$4,046,171 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $32,396,570 | TotalAssetsBOYAmt |
| Total Assets EOY | $27,284,376 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $20,931,895 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $20,929,121 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $11,464,675 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $6,355,255 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | AS A "NONPROFIT BIOTECH," IDRI COMBINES THE HIGH-QUALITY SCIENCE OF A RESEARCH ORGANIZATION WITH THE PRODUCT DEVELOPMENT CAPABILITIES OF A BIOTECH COMPANY TO CREATE NEW DIAGNOSTICS, DRUGS AND VACCINES FOR INFECTIOUS DISEASES AND IMPROVE THE HEALTH OF THE WORLD. | MissionDesc |
| Significant New Program Srvc | 0 | SignificantNewProgramSrvcInd |
| Significant Change | Yes (1) | SignificantChangeInd |
| Expense | $10,468,405 | ExpenseAmt |
| Grant | $57,150 | GrantAmt |
| Revenue | $4,156,285 | RevenueAmt |
| Desc | VACCINE RESEARCH - ONE OF THE GREATEST TRIUMPHS OF PUBLIC HEALTH, VACCINES HAVE BEEN USED FOR DECADES TO BOOST IMMUNITY AND PROTECT AGAINST SERIOUS DISEASES. IDRI SCIENTISTS ARE DEVELOPING INNOVATIVE VACCINES AGAINST DEADLY INFECTIOUS DISEASES SUCH AS TUBERCULOSIS, LEISHMANIASIS, AND LEPROSY, AS WELL AS NEWLY EMERGING THREATS INCLUDING ZIKA AND CHIKUNGUNYA. THE GOAL OF IDRI'S VACCINE WORK IS TO PRODUCE SAFE, EFFECTIVE AND LOW-COST VACCINES AND TO TRANSFER VACCINE TECHNOLOGY AND EXPERTISE TO DEVELOPING COUNTRIES SO THAT VACCINES CAN BE DEVELOPED QUICKLY WHEN DISEASE OUTBREAKS OCCUR. IDRI'S LEADING TUBERCULOSIS VACCINE CANDIDATE (ID93 + GLA-SE) HAS MOVED SUCCESSFULLY THROUGH A PHASE 2A CLINICAL TRIAL IN SOUTH AFRICA TO ASSESS THE ABILITY TO REDUCE TB RECURRENCE AFTER TREATMENT WAS RECENTLY COMPLETED. IDRI'S LEPROSY VACCINE CANDIDATE IS NOW IN CLINICAL TRIALS IN THE U.S. IDRI SCIENTISTS ARE NOW FOCUSED ON DEVELOPING A MORE ROBUST, VERSATILE PLATFORM, FOCUSING ON RNA VACCINES THAT COULD SHORTEN THE TIME IT TAKES TO DEVELOP VACCINES IN CASE OF AN OUTBREAK. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $4,475,718 | ExpenseAmt |
| Grant | $30,000 | GrantAmt |
| Revenue | $1,378,293 | RevenueAmt |
| Desc | TUBERCULOSIS DRUG DISCOVERY - IDRI'S TUBERCULOSIS DRUG DISCOVERY GROUP IS FOCUSED ON DISCOVERING AND DEVELOPING NOVEL DRUGS THAT ARE EFFECTIVE AT CURING DRUG SENSITIVE AND DRUG RESISTANT TB WITH THE ADDED GOAL OF SHORTENING THE TIME IT TAKES TO CURE DISEASE. TO DATE, SCIENTISTS AT IDRI HAVE SCREENED MORE THAN HALF A MILLION COMPOUNDS, CONTINUING THE IDENTIFICATION OF NEW LEADS AND DRUG TARGETS TO COMBAT TB.IDRI IS A FOUNDING MEMBER OF THE LILLY TB DRUG DISCOVERY INITIATIVE - HEADQUARTERED AT IDRI - AND THE TB DRUG ACCELERATOR (TBDA). THE LILLY INITIATIVE IS A UNIQUE PUBLIC-PRIVATE PARTNERSHIP WITH ELI LILLY AND COMPANY AND THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES (NIAID), PART OF THE NATIONAL INSTITUTES OF HEALTH (NIH), WITH A FOCUS ON THE DISCOVERY OF NEW ANTI-TUBERCULOSIS DRUGS. THE TBDA WAS FOUNDED AS A PARTNERSHIP OF SEVEN PHARMACEUTICAL COMPANIES AND FIVE OTHER ORGANIZATIONS, FUNDED IN PART BY THE BILL & MELINDA GATES FOUNDATION, TO TARGET THE DISCOVERY OF NEW TB DRUGS BY COLLABORATING ON EARLY-STAGE DRUG DISCOVERY FOR TUBERCULOSIS. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $2,655,254 | ExpenseAmt |
| Grant | $178,145 | GrantAmt |
| Revenue | $1,446,299 | RevenueAmt |
| Desc | IDRI'S CLINICAL GROUP DESIGNS AND CONDUCTS EARLY STAGE CLINICAL TRIALS TO TEST THE VACCINE CANDIDATES IDENTIFIED BY IDRI SCIENTISTS OR COLLABORATORS. THROUGH OUR NETWORK OF GLOBAL CONNECTIONS, THE CLINICAL TEAM IS ABLE TO LAUNCH CLINICAL TRIALS ALMOST ANYWHERE IN THE WORLD. | Desc |
Prog Srvc Accom Acty Other ProgSrvcAccomActyOtherGrp (2 entries)
| ExpenseExpenseAmt | RevenueRevenueAmt | DescDesc |
|---|---|---|
| $1,812,702 | $2,803,704 | ADJUVANT RESEARCH - ADJUVANTS ARE SUBSTANCES ADDED TO VACCINES THAT ENHANCE THE ABILITY OF ANTIGENS TO STIMULATE THE BODY'S IMMUNE RESPONSE. THEY PROVIDE A KEY BENEFIT TO VACCINE DEVELOPMENT BY: IMPROVING IMMUNE RESPONSE, BROADENING VACCINE PROTECTION AND REDUCING THE AMOUNT OF VACCINE NEEDED.IDRI IS A WORLD LEADER IN ADJUVANT DEVELOPMENT AND HAS DEVELOPED MULTIPLE ADJUVANT FORMULATIONS. IN ADDITION TO VACCINES THAT IDRI IS DEVELOPING FOR TUBERCULOSIS, LEPROSY AND LEISHMANIASIS, IDRI SCIENTISTS ARE ALSO WORKING WITH COLLABORATORS TO PROVIDE ADJUVANTS FOR VACCINES BEING DEVELOPED IN VARIOUS DISEASE AREAS, INCLUDING MALARIA, HIV/AIDS, ZIKA AND PANDEMIC FLU. IN ADDITION, IDRI HAS TRANSFERRED ITS ADJUVANT TECHNOLOGIES TO ROMANIA, BRAZIL, SOUTH AFRICA AND INDIA, WHERE IDRI SCIENTISTS TEACH SCIENTISTS AND ENGINEERS HOW TO MANUFACTURE ADJUVANTS FOR THEIR OWN VACCINES. |
| $1,307,207 | $1,374,980 | MANUFACTURING - ONCE A VACCINE CANDIDATE HAS BEEN IDENTIFIED IN THE RESEARCH LAB, THE NEXT CHALLENGE IS TO APPLY THAT DISCOVERY TO THE CLINICAL SETTING. A NECESSARY PART OF THIS TRANSITION IS TO PRODUCE VACCINES UNDER CONTROLLED CONDITIONS SO THAT THEY ARE SUITABLE FOR USE IN HUMAN STUDIES. IDRI HAS DEVELOPED THE TYPE OF MANUFACTURING CAPABILITY REQUIRED TO MOVE A VACCINE FROM LATE STAGE RESEARCH TO EARLY CLINICAL STUDIES. |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Other Prog Srvc Expense | $3,119,909 | TotalOtherProgSrvcExpenseAmt |
| Total Other Prog Srvc Revenue | $4,178,684 | TotalOtherProgSrvcRevenueAmt |
| Total Program Service Expenses | $20,719,286 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (1) | DescribedInSection501c3Ind |
| Schedule B Required | Yes (1) | ScheduleBRequiredInd |
| Political Campaign Acty | 0 | PoliticalCampaignActyInd |
| Lobbying Activities | 0 | LobbyingActivitiesInd |
| Subject To Proxy Tax | 0 | SubjectToProxyTaxInd |
| Donor Advised Fund | 0 | DonorAdvisedFundInd |
| Conservation Easements | 0 | ConservationEasementsInd |
| Collections Of Art | 0 | CollectionsOfArtInd |
| Credit Counseling | 0 | CreditCounselingInd |
| Temp Or Permanent Endowments | 0 | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (1) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | 0 | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | 0 | ReportProgramRelatedInvstInd |
| Report Other Assets | 0 | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (1) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | 0 | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | 0 | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (1) | ConsolidatedAuditFinclStmtInd |
| School Operating | 0 | SchoolOperatingInd |
| Foreign Office | 0 | ForeignOfficeInd |
| Foreign Activities | Yes (1) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (1) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | 0 | MoreThan5000KToIndividualsInd |
| Professional Fundraising | 0 | ProfessionalFundraisingInd |
| Fundraising Activities | 0 | FundraisingActivitiesInd |
| Gaming Activities | 0 | GamingActivitiesInd |
| Operate Hospital | 0 | OperateHospitalInd |
| Grants To Organizations | Yes (1) | GrantsToOrganizationsInd |
| Grants To Individuals | 0 | GrantsToIndividualsInd |
| Schedule J Required | Yes (1) | ScheduleJRequiredInd |
| Tax Exempt Bonds | 0 | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | 0 | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | 0 | PYExcessBenefitTransInd |
| Loan Outstanding | 0 | LoanOutstandingInd |
| Grant To Related Person | 0 | GrantToRelatedPersonInd |
| Business Rln With Org Mem | 0 | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | 0 | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | 0 | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | 0 | DeductibleNonCashContriInd |
| Deductible Art Contribution | 0 | DeductibleArtContributionInd |
| Terminate Operations | 0 | TerminateOperationsInd |
| Partial Liquidation | 0 | PartialLiquidationInd |
| Disregarded Entity | 0 | DisregardedEntityInd |
| Related Entity | Yes (1) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (1) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | Yes (1) | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | 0 | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | 0 | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (1) | ScheduleORequiredInd |
| IRP Document | 32 | IRPDocumentCnt |
| IRP Document W2 G | 0 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (1) | BackupWthldComplianceInd |
| Employee | 160 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (1) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | 0 | UnrelatedBusIncmOverLimitInd |
| Foreign Financial Account | Yes (1) | ForeignFinancialAccountInd |
| Foreign Country | SF | ForeignCountryCd |
| Prohibited Tax Shelter Trans | 0 | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | 0 | TaxablePartyNotificationInd |
| Nondeductible Contributions | 0 | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | 0 | QuidProQuoContributionsInd |
| Form8282 Property Disposed Of | 0 | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | 0 | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | 0 | PayPremiumsPrsnlBnftCntrctInd |
| Indoor Tanning Services | 0 | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 11 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 8 | IndependentVotingMemberCnt |
| Family Or Business Rln | 0 | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | 0 | DelegationOfMgmtDutiesInd |
| Change To Org Documents | 0 | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | 0 | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | 0 | MembersOrStockholdersInd |
| Election Of Board Members | 0 | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | 0 | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (1) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | 0 | MinutesOfCommitteesInd |
| Officer Mailing Address | 0 | OfficerMailingAddressInd |
| Local Chapters | 0 | LocalChaptersInd |
| Form990 Provided To Gvrn Body | Yes (1) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (1) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (1) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (1) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (1) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (1) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (1) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (1) | CompensationProcessOtherInd |
| Investment In Joint Venture | Yes (1) | InvestmentInJointVentureInd |
| Written Policy Or Procedure | 0 | WrittenPolicyOrProcedureInd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | RICHARD LAUTCH | PersonNm |
| Phone | 2068586053 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 1616 EASTLAKE AVE E SUITE 400 | AddressLine1Txt |
| City | SEATTLE | CityNm |
| State Abbreviation | WA | StateAbbreviationCd |
| ZIP | 98102 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (23 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | OfficerOfficerInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| BRUCE CARTER PHD | |||||||||
| CHAIRMAN | 5.00 | 0.00 | Yes (X) | Yes (X) | $0 | $0 | $0 | ||
| NORMAN BAYLOR PHD | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| GAIL CASSEL PHD | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $27,480 | $0 | $0 | |||
| MICHEL DEWILDE PHD | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| ERIK IVERSON JD LLM | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| CHRIS HENTSCHEL PHD | |||||||||
| DIRECTOR THRU 02/17 | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| FRANKLYN PRENDERGAST MD PHD | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| MASSIMO RADAELLI PHD | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| KARI STOEVER | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| RICHARD LAUTCH | |||||||||
| DIRECTOR | 5.00 | 0.00 | Yes (X) | $31,875 | $0 | $0 | |||
| CINDY RUNGER | |||||||||
| DIRECTOR | 1.00 | 0.00 | Yes (X) | $0 | $0 | $0 | |||
| C STEPHEN CORDIAL MBA | |||||||||
| CFO/DIRECTOR | 40.00 | 0.00 | Yes (X) | Yes (X) | $210,265 | $0 | $13,046 | ||
| STEVEN REED PHD | |||||||||
| PRESIDENT & CEO/DIRECTOR | 32.00 | 0.10 | Yes (X) | Yes (X) | $350,123 | $0 | $22,941 | ||
| DOUGLAS BRADLEY | |||||||||
| GENERAL COUNSEL/SECRETARY | 40.00 | 0.00 | Yes (X) | $179,290 | $0 | $11,721 | |||
| ANNA MARIE BECKMANN PHD | |||||||||
| SVP, PRODUCT DEVELOPMENT & REGULATORY | 40.00 | 0.00 | $199,400 | $0 | $24,018 | Yes (X) | |||
| TANYA PARISH PHD | |||||||||
| SVP, DRUG DISCOVERY | 40.00 | 0.00 | $188,624 | $0 | $6,956 | Yes (X) | |||
| COREY CASPER | |||||||||
| CHIEF MEDICAL OFFICER | 40.00 | 0.00 | $184,381 | $0 | $13,841 | Yes (X) | |||
| DAN STINCHCOMB | |||||||||
| CHIEF SCIENTIFIC OFFICER | 40.00 | 0.00 | $255,131 | $0 | $26,180 | Yes (X) | |||
| WINSTON WICOMB | |||||||||
| DIRECTOR, VIVARIUM | 40.00 | 0.00 | $166,348 | $0 | $16,291 | Yes (X) | |||
| CHRISTOPHER FOX | |||||||||
| VP, FORMULATIONS | 40.00 | 0.00 | $156,808 | $0 | $22,968 | Yes (X) | |||
| LEE SCHOENTRUP | |||||||||
| DIR., COMMUNICATIONS | 40.00 | 0.00 | $143,720 | $0 | $9,651 | Yes (X) | |||
| CHRISTOPHER ANTONY | |||||||||
| VP, OPERATIONS - EH&S OFFICER | 40.00 | 0.00 | $139,504 | $0 | $10,080 | Yes (X) | |||
| LINDA HAWKINS | |||||||||
| DIR., QUALITY ASSURANCE & COMPLIANCE | 40.00 | 0.00 | $136,474 | $0 | $10,055 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $2,369,423 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $187,748 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 21 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | 0 | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (1) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | 0 | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (4 entries)
| Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd | ServicesServicesDesc | CompensationCompensationAmt |
|---|---|---|---|---|---|
| MORRISON & FOERSTER LLP | |||||
| PO BOX 742335 | LOS ANGELES | CA | 90074 | LEGAL SERVICES | $691,089 |
| UNIVERSITY OF IOWA - CBB | |||||
| 2501 CROSSPARK RD STE C100 | CORALVILLE | IA | 52241 | RESEARCH | $400,000 |
| IIT RESEARCH INSTITUTE | |||||
| 10 W 35TH ST 8TH FLOOR | CHICAGO | IL | 60616 | RESEARCH | $347,682 |
| CYPROTEX US LLC | |||||
| 313 PLEASANT ST | WATERTOWN | MA | 02472 | RESEARCH | $152,582 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 4 | CntrctRcvdGreaterThan100KCnt |
| Government Grants | $10,480,867 | GovernmentGrantsAmt |
| All Other Contributions | $1,175,253 | AllOtherContributionsAmt |
| Total Contributions | $11,656,120 | TotalContributionsAmt |
Program Service Revenue ProgramServiceRevenueGrp (2 entries)
| DescDesc | BusinessBusinessCd | Total Revenue ColumnTotalRevenueColumnAmt | Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt |
|---|---|---|---|
| SERVICES AND CONTRACTS | 541700 | $10,259,561 | $10,259,561 |
| LICENSING | 541700 | $900,000 | $900,000 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Revenue | $11,159,561 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $24,767 | TotalRevenueColumnAmt |
| Exclusion | $24,767 | ExclusionAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $916,304 | TotalRevenueColumnAmt |
| Exclusion | $916,304 | ExclusionAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $997,885 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,000,000 | SecuritiesAmt |
| Other | $235,484 | OtherAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | -$2,115 | SecuritiesAmt |
| Other | -$235,484 | OtherAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | -$237,599 | TotalRevenueColumnAmt |
| Exclusion | -$237,599 | ExclusionAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | LIABILITY REVERSAL | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $70,307 | TotalRevenueColumnAmt |
| Exclusion | $70,307 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $70,307 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $23,589,460 | TotalRevenueColumnAmt |
| Related Or Exempt Func Income | $11,159,561 | RelatedOrExemptFuncIncomeAmt |
| Unrelated Business Revenue | $0 | UnrelatedBusinessRevenueAmt |
| Exclusion | $773,779 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $77,657 | TotalAmt |
| Program Services | $77,657 | ProgramServicesAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $187,638 | TotalAmt |
| Program Services | $187,638 | ProgramServicesAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,745,271 | TotalAmt |
| Program Services | $1,003,296 | ProgramServicesAmt |
| Management And General | $741,975 | ManagementAndGeneralAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $9,027,746 | TotalAmt |
| Program Services | $6,625,430 | ProgramServicesAmt |
| Management And General | $2,384,547 | ManagementAndGeneralAmt |
| Fundraising | $17,769 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $304,655 | TotalAmt |
| Program Services | $224,307 | ProgramServicesAmt |
| Management And General | $79,722 | ManagementAndGeneralAmt |
| Fundraising | $626 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,248,381 | TotalAmt |
| Program Services | $889,265 | ProgramServicesAmt |
| Management And General | $356,867 | ManagementAndGeneralAmt |
| Fundraising | $2,249 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $810,981 | TotalAmt |
| Program Services | $576,058 | ProgramServicesAmt |
| Management And General | $233,528 | ManagementAndGeneralAmt |
| Fundraising | $1,395 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $542,390 | TotalAmt |
| Program Services | $31,399 | ProgramServicesAmt |
| Management And General | $510,991 | ManagementAndGeneralAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $81,084 | TotalAmt |
| Management And General | $81,084 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,525,381 | TotalAmt |
| Program Services | $1,421,630 | ProgramServicesAmt |
| Management And General | $103,705 | ManagementAndGeneralAmt |
| Fundraising | $46 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $24,964 | TotalAmt |
| Program Services | $10,537 | ProgramServicesAmt |
| Management And General | $14,366 | ManagementAndGeneralAmt |
| Fundraising | $61 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $369,573 | TotalAmt |
| Program Services | $63,295 | ProgramServicesAmt |
| Management And General | $303,832 | ManagementAndGeneralAmt |
| Fundraising | $2,446 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $299,883 | TotalAmt |
| Program Services | $55,300 | ProgramServicesAmt |
| Management And General | $244,583 | ManagementAndGeneralAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $542,758 | TotalAmt |
| Management And General | $542,758 | ManagementAndGeneralAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,773,081 | TotalAmt |
| Program Services | $2,241,619 | ProgramServicesAmt |
| Management And General | $526,131 | ManagementAndGeneralAmt |
| Fundraising | $5,331 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $327,309 | TotalAmt |
| Program Services | $263,876 | ProgramServicesAmt |
| Management And General | $63,362 | ManagementAndGeneralAmt |
| Fundraising | $71 | FundraisingAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $48,537 | TotalAmt |
| Program Services | $14,624 | ProgramServicesAmt |
| Management And General | $33,913 | ManagementAndGeneralAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,866,942 | TotalAmt |
| Program Services | $1,655,567 | ProgramServicesAmt |
| Management And General | $211,375 | ManagementAndGeneralAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $134,387 | TotalAmt |
| Management And General | $134,387 | ManagementAndGeneralAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt |
|---|---|---|---|
| LAB SUPPLIES | $3,502,301 | $3,470,632 | $31,669 |
| SUBCONTRACTS | $1,417,268 | $1,417,268 | |
| REPAIRS & MAINTENANCE | $599,515 | $447,356 | $152,159 |
All Other Expenses AllOtherExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $177,929 | TotalAmt |
| Program Services | $42,532 | ProgramServicesAmt |
| Management And General | $121,977 | ManagementAndGeneralAmt |
| Fundraising | $13,420 | FundraisingAmt |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $27,635,631 | TotalAmt |
| Program Services | $20,719,286 | ProgramServicesAmt |
| Management And General | $6,872,931 | ManagementAndGeneralAmt |
| Fundraising | $43,414 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,431,008 | BOYAmt |
| EOY | $2,038,947 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,136,852 | BOYAmt |
| EOY | $3,396,269 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,207,488 | BOYAmt |
| EOY | $3,429,127 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,270,974 | BOYAmt |
| EOY | $1,737,493 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $755,515 | BOYAmt |
| EOY | $662,421 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $249,908 | BOYAmt |
| EOY | $304,999 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $28,008,494 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $12,419,403 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,109,341 | BOYAmt |
| EOY | $15,589,091 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $235,484 | BOYAmt |
| EOY | $0 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $121,354 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $4,675 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,396,570 | BOYAmt |
| EOY | $27,284,376 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $3,117,505 | BOYAmt |
| EOY | $2,660,016 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $1,932,887 | BOYAmt |
| EOY | $3,411,588 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,881,503 | BOYAmt |
| EOY | $14,857,517 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $20,931,895 | BOYAmt |
| EOY | $20,929,121 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,283,722 | BOYAmt |
| EOY | $2,138,839 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $9,180,953 | BOYAmt |
| EOY | $4,216,416 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $11,464,675 | BOYAmt |
| EOY | $6,355,255 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,396,570 | BOYAmt |
| EOY | $27,284,376 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Info In Schedule O Part XI | Yes (X) | InfoInScheduleOPartXIInd |
| Reconcilation Revenue Expnss | -$4,046,171 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $706 | NetUnrlzdGainsLossesInvstAmt |
| Other Changes In Net Assets | -$1,063,955 | OtherChangesInNetAssetsAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | 0 | AccountantCompileOrReviewInd |
| FS Audited | Yes (1) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (1) | AuditCommitteeInd |
| Federal Grant Audit Required | Yes (1) | FederalGrantAuditRequiredInd |
| Federal Grant Audit Performed | Yes (1) | FederalGrantAuditPerformedInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,743,860 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $9,413,720 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $19,664,811 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $10,055,782 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $11,656,120 | CurrentTaxYearAmt |
| Total | $62,534,293 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $11,743,860 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $9,413,720 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $19,664,811 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $10,055,782 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $11,656,120 | CurrentTaxYearAmt |
| Total | $62,534,293 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $10,794,667 | SubstantialContributorsTotAmt |
| Public Support Total170 | $51,739,626 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $683,996 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $727,807 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $1,672,937 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $1,003,630 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $941,071 | CurrentTaxYearAmt |
| Total | $5,029,441 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $500 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus2 Years | $11,373 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $8,216 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $70,307 | CurrentTaxYearAmt |
| Total | $90,396 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $67,654,130 | TotalSupportAmt |
| Gross Receipts Rltd Activities | $31,258,700 | GrossReceiptsRltdActivitiesAmt |
| Public Support CY170 | 0.76480 | PublicSupportCY170Pct |
| Public Support PY170 | 0.67420 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Form990 Schedule A Part VI Form990ScheduleAPartVIGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: | FormAndLineReferenceDesc |
| Explanation | MISCELLANEOUS - 2013 AMOUNT: $ 500. 2017 AMOUNT: $ 70,307. REIMBURSEMENTS - 2016 AMOUNT: $ 413. STORAGE - 2016 AMOUNT: $ 7,803. CURRENCY EXCHANGE - 2015 AMOUNT: $ 11,373. | ExplanationTxt |
Schedule B IRS990ScheduleB
Schedule D IRS990ScheduleD
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $15,203,205 | OtherCostOrOtherBasisAmt |
| Depreciation | $4,814,348 | DepreciationAmt |
| Book Value | $10,388,857 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $12,805,289 | OtherCostOrOtherBasisAmt |
| Depreciation | $7,605,055 | DepreciationAmt |
| Book Value | $5,200,234 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Land Buildings | $15,589,091 | TotalBookValueLandBuildingsAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | DEFERRED RENT | Desc |
| Amt | $14,857,517 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $14,857,517 | TotalLiabilityAmt |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | 0 | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)
| RegionRegionTxt | OfficesOfficesCnt | EmployeeEmployeeCnt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt |
|---|---|---|---|---|---|
| SOUTH ASIA | 0 | 0 | PROGRAM SERVICES | RESEARCH | $539,389 |
| EUROPE (INCLUDING ICELAND & GREENLAND) | 0 | 0 | PROGRAM SERVICES | RESEARCH | $225,291 |
| NORTH AMERICA | 0 | 0 | PROGRAM SERVICES | RESEARCH | $2,536 |
| SUB-SAHARAN AFRICA | 0 | 0 | PROGRAM SERVICES | RESEARCH | $241,702 |
| SOUTH ASIA | 0 | 0 | GRANTMAKING | N/A | $9,493 |
| EAST ASIA AND THE PACIFIC | 0 | 0 | GRANTMAKING | N/A | $178,145 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 0 | SubtotalOfficesCnt |
| Subtotal Employees | 0 | SubtotalEmployeesCnt |
| Continuation Total Office | 0 | ContinuationTotalOfficeCnt |
| Continuation Total Employee | 0 | ContinuationTotalEmployeeCnt |
| Total Office | 0 | TotalOfficeCnt |
| Total Employee | 0 | TotalEmployeeCnt |
| Subtotal Spent | $1,196,556 | SubtotalSpentAmt |
| Continuation Spent | $0 | ContinuationSpentAmt |
| Total Spent | $1,196,556 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt |
|---|---|---|---|
| EAST ASIA AND THE PACIFIC | RESEARCH | $178,145 | WIRE TRANSFER |
| SOUTH ASIA | RESEARCH | $9,493 | WIRE TRANSFER |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 2 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | 0 | TransferToForeignCorpInd |
| Interest In Foreign Trust | 0 | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (1) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | 0 | PassiveForeignInvestmestCoInd |
| Foreign Partnership | 0 | ForeignPartnershipInd |
| Boycott Countries | 0 | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 3: | FormAndLineReferenceDesc |
| Explanation | THE EXPENDITURES REPORTED ON SCHEDULE F, PART I, LINE 3 ARE ON ACCRUAL BASIS OF ACCOUNTING. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (1) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (3 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc | Purpose Of GrantPurposeOfGrantTxt | Address Line2USAddress/AddressLine2Txt |
|---|---|---|---|---|---|---|---|---|---|---|
| NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES | ||||||||||
| 5601 FISHERS LANE MSC 9804 | BETHESDA | MD | 20892 | 520858115 | GOVERNMENT | $30,000 | N/A | N/A | RESEARCH | |
| UNIVERSITY OF GEORGIA RESEARCH FOUNDATION INC | ||||||||||
| 310 EAST CAMPUS RD TUCKER HALL ROOM | ATHENS | GA | 30602 | 581353149 | 501(C)(3) | $12,817 | N/A | N/A | RESEARCH | 411 |
| UNIVERSITY OF VIRGINIA | ||||||||||
| PO BOX 400195 | CHARLOTTESVILLE | VA | 22904 | 546001796 | 501(C)(3) | $34,839 | N/A | N/A | RESEARCH | |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 3 | Total501c3OrgCnt |
| Total Other Org | 0 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 2: | FormAndLineReferenceDesc |
| Explanation | ALL PAYMENTS MADE FOR PROGRAM SERVICES WITHIN THE U.S. ARE BASED ON LEGAL AGREEMENTS BETWEEN IDRI AND THE PARTY RECEIVING PAYMENT. THESE AGREEMENTS INCLUDE REQUIREMENTS FOR BOTH PROGRESS AND FINANCIAL REPORTING BASED ON TIME PERIODS OR MILESTONE ACHIEVEMENTS. REPORTS ARE REVIEWED BY SCIENTIFIC AND ADMINISTRATIVE STAFF TO ENSURE THAT THE GOALS OF THE AGREEMENT AND ANY SPECIFIC FINANCIAL RESTRICTIONS ARE BEING MET BEFORE FURTHER PAYMENT IS MADE. MOST AGREEMENTS ALSO CONTAIN A CLAUSE GIVING IDRI THE RIGHT TO AUDIT FINANCIAL RECORDS OF THE PARTY IF NEEDED. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | 0 | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | 0 | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | 0 | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | Yes (1) | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | 0 | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | 0 | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | 0 | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | 0 | AnyNonFixedPaymentsInd |
| Initial Contract Exception | 0 | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt | Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| C STEPHEN CORDIAL MBA | ||||||||||||||
| CFO/DIRECTOR | $210,265 | $0 | $0 | $0 | $0 | $0 | $8,625 | $0 | $4,421 | $0 | $223,311 | $0 | $0 | $0 |
| STEVEN REED PHD | ||||||||||||||
| PRESIDENT & CEO/DIRECTOR | $350,123 | $0 | $0 | $0 | $0 | $0 | $10,800 | $0 | $12,141 | $0 | $373,064 | $0 | $0 | $0 |
| DOUGLAS BRADLEY | ||||||||||||||
| GENERAL COUNSEL/SECRETARY | $179,290 | $0 | $0 | $0 | $0 | $0 | $7,300 | $0 | $4,421 | $0 | $191,011 | $0 | $0 | $0 |
| ANNA MARIE BECKMANN PHD | ||||||||||||||
| SVP, PRODUCT DEVELOPMENT & REGULATOR | $199,400 | $0 | $0 | $0 | $0 | $0 | $8,088 | $0 | $15,930 | $0 | $223,418 | $0 | $0 | $0 |
| TANYA PARISH PHD | ||||||||||||||
| SVP, DRUG DISCOVERY | $188,624 | $0 | $0 | $0 | $0 | $0 | $6,956 | $0 | $0 | $0 | $195,580 | $0 | $0 | $0 |
| COREY CASPER | ||||||||||||||
| CHIEF MEDICAL OFFICER | $184,381 | $0 | $0 | $0 | $0 | $0 | $7,500 | $0 | $6,341 | $0 | $198,222 | $0 | $0 | $0 |
| DAN STINCHCOMB | ||||||||||||||
| CHIEF SCIENTIFIC OFFICER | $255,131 | $0 | $0 | $0 | $0 | $0 | $10,250 | $0 | $15,930 | $0 | $281,311 | $0 | $0 | $0 |
| WINSTON WICOMB | ||||||||||||||
| DIRECTOR, VIVARIUM | $166,348 | $0 | $0 | $0 | $0 | $0 | $6,437 | $0 | $9,854 | $0 | $182,639 | $0 | $0 | $0 |
| CHRISTOPHER FOX | ||||||||||||||
| VP, FORMULATIONS | $156,808 | $0 | $0 | $0 | $0 | $0 | $6,439 | $0 | $16,529 | $0 | $179,776 | $0 | $0 | $0 |
| LEE SCHOENTRUP | ||||||||||||||
| DIR., COMMUNICATIONS | $143,720 | $0 | $0 | $0 | $0 | $0 | $5,800 | $0 | $3,851 | $0 | $153,371 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | PART I, LINE 5 | FormAndLineReferenceDesc |
| Explanation | INVENTOR REVENUES SHARED WITH STEVEN R. REED AND OTHER PATENT HOLDERS WHEN IP IS LICENSED. | ExplanationTxt |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (9 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| FORM 990, PART 1, LINE 6: | THERE WERE EIGHT VOLUNTEER BOARD MEMBERS DURING THE YEAR. BOARD MEMBERS PARTICIPATE IN STRATEGIC PLANNING, FINANCIAL OVERSIGHT, EXECUTIVE LEADERSHIP RECRUITMENT AND SELECTION, BUSINESS DEVELOP STRATEGY, AND SCIENTIFIC ADVICE. THEY COME FROM A VARIETY OF BACKGROUNDS AND DEMONSTRATE FINANCIAL EXPERTISE, LIFE SCIENCES NOT-FOR-PROFIT EXPERTISE, AND AN UNDERSTANDING OF BUSINESS AND BIOTECH LICENSING. |
| FORM 990, PART III, LINE 3 | EFFECTIVE NOVEMBER 16, 2017, INFECTIOUS DISEASE RESEARCH INSTITUTE (IDRI) SOLD ITS INTEREST IN AFRIGEN BIOLOGICS, LLC. THIS ENTITY WAS FORMED BY IDRI FOR LOCAL DEVELOPMENT AND PRODUCTION OF VACCINES, VACCINE TECHNOLOGY AND BIOLOGICS OF CRITICAL IMPORTANCE TO COMBAT INFECTIOUS DISEASES IN AFRICA. |
| FORM 990, PART VI, SECTION A, LINE 1 | THE FOLLOWING VOTING MEMBERS OF THE BOARD ARE NOT INDEPENDENT AT YEAR END: STEVEN R. REED (PRESIDENT & CEO); C. STEPHEN CORDIAL (CFO); RICHARD LAUTCH WHO PROVIDED CONSULTING SERVICES. |
| FORM 990, PART VI, SECTION A, LINE 8B | THE FINANCE & AUDIT COMMITTEE MET REGULARLY AND TOOK MINUTES. THE FULL BOARD REVIEWED COMPENSATION IN 2017 AND SO THE COMPENSATION COMMITTEE DID NOT MEET THAT YEAR. THE NOMINATING & GOVERNANCE COMMITTEE DID NOT MEET. |
| FORM 990, PART VI, SECTION B, LINE 11B | A DRAFT COPY OF THE FORM 990 IS PRESENTED TO THE AUDIT COMMITTEE FOR REVIEW. THE AUDIT COMMITTEE REVIEWS AND APPROVES THE FORM 990 ON BEHALF OF THE IDRI BOARD OF DIRECTORS. ALL BOARD MEMBERS RECEIVE A COPY OF THE FORM 990 PRIOR TO FILING WITH THE IRS. |
| FORM 990, PART VI, SECTION B, LINE 12C | EACH JANUARY, MEMBERS OF THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT ARE GIVEN A COPY OF THE CONFLICT OF INTEREST POLICY. THEY ARE REQUIRED TO FILL IT OUT AND RETURN IT BY THE FIRST BOARD MEETING - USUALLY SOMETIME IN THE FIRST QUARTER. THE SENIOR VICE PRESIDENT OF OPERATIONS AND GENERAL COUNSEL REVIEWS THE QUESTIONNAIRES AND SUMMARIZES THE RESULTS. THE RESULTS ARE COMMUNICATED TO THE BOARD OF DIRECTORS. TO THE EXTENT THAT THERE ARE ANY CONFLICTS, THE MEMBER IS RECUSED FROM ANY DECISION MAKING THAT WOULD INCLUDE THE CONFLICT. WHEN THE OCCASION ARISES, THOSE MEMBERS ALSO REMIND THE GROUP (MANAGEMENT TEAM OR BOARD) THAT THERE IS A POTENTIAL CONFLICT WHEN SPECIFIC DISCUSSION TOPICS ARISE. |
| FORM 990, PART VI, SECTION B, LINE 15 | THE COMPENSATION COMMITTEE CONDUCTED A FULL CEO PERFORMANCE AND COMPENSATION REVIEW, INITIATED IN NOVEMBER 2016, USING AN OUTSIDE INDEPENDENT CONSULTANT. THE REPORT IS IN THE BOARD MATERIALS AND IN THE PERSONNEL FILE. THE DECISIONS ARE IN THE COMPENSATION COMMITTEE NOTES. COMPARATIVE COMPENSATION INFORMATION WAS USED FROM THE CULPEPPER AND RADFORD PROFESSIONAL COMPENSATION FIRMS. THE BOARD CHAIR ALSO DOES AN ANNUAL REVIEW OF ALL OTHER OFFICERS AND KEY EMPLOYEES AND WORKS WITH THE HUMAN RESOURCES DEPARTMENT TO DETERMINE IF THE COMPENSATION IS ADEQUATE. IF AN ADJUSTMENT IS DEEMED NECESSARY, THE BOARD CHAIR CONVENES THE COMPENSATION COMMITTEE AND THE ADJUSTMENT IS ADDRESSED. THE BOARD CHAIR REPORTS BACK TO THE HUMAN RESOURCES DEPARTMENT WHO FOLLOWS THROUGH WITH THE COMMITTEE'S RECOMMENDATION. |
| FORM 990, PART VI, SECTION C, LINE 19 | THE IDRI AUDITED FINANCIAL STATEMENTS ARE AVAILABLE ON OUR WEBSITE, WWW.IDRI.ORG. REQUESTS FOR OTHER INFORMATION SUCH AS GOVERNING DOCUMENTS AND CONFLICT OF INTEREST POLICY ARE HANDLED THROUGH OUR FINANCE DEPARTMENT AND INFORMATION IS DISTRIBUTED AS REQUESTED UNLESS CONFIDENTIAL IN NATURE. |
| FORM 990, PART XI, LINE 9: | LOSS ON UNCOLLECTIBLE PLEDGE -1,075,119. DISCOUNT ON LONG TERM PLEDGE 11,164. |
Schedule R IRS990ScheduleR
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AFRIGEN BIOLOGICS (PTY) LTD | BusinessNameLine1Txt |
Foreign Address ForeignAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 37 STRAND STREET | AddressLine1Txt |
| City | CAPE TOWN | CityNm |
| Province Or State | WESTERN CAPE | ProvinceOrStateNm |
| Country | SF | CountryCd |
| Foreign Postal | 8001 | ForeignPostalCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | RESEARCH | PrimaryActivitiesTxt |
| Legal Domicile Foreign Country | SF | LegalDomicileForeignCountryCd |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | INFECTIOUS DISEASE RESEARCH INSTITUTE | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Entity Type | C | EntityTypeTxt |
| Share Of Total Income | -$322,354 | ShareOfTotalIncomeAmt |
| Controlled Organization | Yes (1) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | 0 | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | 0 | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | 0 | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | 0 | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | 0 | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | 0 | DivRelatedOrganizationInd |
| Asset Sale To Other Org | 0 | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | 0 | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | 0 | AssetExchangeInd |
| Rental Of Facilities To Oth Org | 0 | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | 0 | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | 0 | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | 0 | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | 0 | SharingOfFacilitiesInd |
| Paid Employees Sharing | 0 | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | 0 | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | 0 | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | 0 | TransferToOtherOrgInd |
| Transfer From Other Org | 0 | TransferFromOtherOrgInd |
Transactions Related Org TransactionsRelatedOrgGrp
Other Organization Name OtherOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | AFRIGEN BIOLOGICS (PTY) LTD | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Transaction Type | D | TransactionTypeTxt |
| Involved | $0 | InvolvedAmt |
| Method Of Amount Determination | COST | MethodOfAmountDeterminationTxt |